{
  "docId": "019de06f-57cf-712e-a58f-75e608a89acf",
  "docSlug": "72cbc476cbb3df5012eb344c4961ce5a",
  "documentTitle": "Bausch Health Companies | Mergers and Acquisitions Presentation Deck | 40 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Valeant",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2014-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.5571777,
  "pageNumber": 12,
  "pageCount": 40,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "appendix_disclosure",
  "function": "cite_precedent",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses authority bias to support the problem statement by citing reputable industry publications.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de06f-57cf-712e-a58f-75e608a89acf/12",
  "deckHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf",
  "deckJsonHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf.json",
  "deckAnchorHref": "/decks/019de06f-57cf-712e-a58f-75e608a89acf#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "image",
      "text": "Harvard Business Review",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "294929ce-a4f8-479d-a607-1e391f7c178f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.05,
        "y": 0.7
      },
      "kind": "image",
      "text": "Nature Chemical Biology",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "76c55860-f281-4f1e-87d1-d4ca4b8b94e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.15,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "image",
      "text": "Nature Reviews",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "efb74822-ba3a-4e4f-8c70-5c687d176041",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.25,
        "y": 0.25
      },
      "kind": "list",
      "text": "the CEO of GlaxoSmithKline, believes that declining R&D productivity is his industry's primary problem - Rebuilding the R&D engine in Big Pharma, 2008",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28a1ea2f-cf04-43e7-8ddf-9199c3966855",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.65,
        "x": 0.25,
        "y": 0.7
      },
      "kind": "list",
      "text": "The pharmaceutical industry is in a period of crisis due to the low number of new drug approvals relative to the high levels of R&D investment. - Getting pharmaceutical R&D back on target, March 2011",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5d52f821-508f-4ce6-8c03-78a1f3a7b83e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.65,
        "x": 0.25,
        "y": 0.45
      },
      "kind": "list",
      "text": "The number of new drugs approved per billion US dollars spent on R&D has halved roughly every 9 years since 1950, falling around 80-fold in inflation-adjusted terms. - Diagnosing the decline in pharmaceutical R&D efficiency, March 2012",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "987ffe38-7ead-4d22-ae60-838badbe4e23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Evidenced by both scientific & business publications",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a72ece58-d4a2-4a88-ba53-0fd2bbf01cba",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "d7c38d16-ca91-480b-867a-852fbc1814b5",
      "evidence": "Citing HBR and Nature to validate industry claims",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 24,
      "from": 11,
      "beatId": "db5c924d-e00d-4a10-88fb-f95fe8125dc5",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "Industry trends, market landscape, and challenges in aesthetics",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}